Westlake Therapeutics
Developing a variety of innovative cell therapy products for rare diseases.
Launch date
Market cap
-
Enterprise valuation
CAD87—131m (Dealroom.co estimates Jan 2021.)
Hangzhou Zhejiang (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$16.0m | Early VC | ||
$16.0m | Series A | ||
CNY100m | Late VC | ||
| Total Funding | CAD62.4m | ||